Tomohiro Fujii

Company: Ajinomoto Bio-Pharma Services

Job title: ADC Researcher

Seminars:

A Versatile Approach to Generating Next-Generation Antibody Conjugates Through AJICAP® Technologies 9:00 am

• AJICAP Conjugation: Leveraging site-specific Technologies in next-generation ADCs to enhance clinically relevant biological properties through precise DAR control such as 1, 2, 4, 8 and higher • AJICAP® Linker: Demonstrating a novel hydrophilic linker technology that enhances stability and enables versatile synthesis of ADCs with higher DAR numbers, even with highly hydrophilic payloads •…Read more

day: Conference Day Two pt 1